Jump to any asset
850 assets, updated daily
As of September 11, 2026, Colgate-Palmolive Co. (CL) trades at $86.74. CleaRank Financial AI rates it Hold with a fair value of $98.95, 14.1% above the current price. Wall Street's consensus target is $100.50 across 21 analysts. RSI at 28 is in oversold territory, and the price is below its 50-day average of $91.47.
Colgate-Palmolive Co. (CL)
Colgate-Palmolive Co. NYSE
$86.74
-1.160 (-1.32%)
Latest Price
AI Analyst Consensus
45 / 100
Colgate-Palmolive Co. (CL) is currently trading at $86.74, below its 50-day and 200-day moving averages ($91.47 and $87.89), indicating a bearish technical trend. The company has demonstrated consistent revenue growth, with current year estimates at +5.00% and next year at +3.00%. Recent earnings have shown positive surprises, with the latest quarter beating estimates by 4.21%. However, significant insider selling, totaling $57.3 million in dispositions, raises concerns about management's short-term confidence. The company operates in the Consumer Defensive sector, specifically Household & Personal Products, a space typically characterized by stable demand. Despite the positive revenue and earnings trends, the current technical setup and insider activity suggest a period of consolidation or potential further downside before a sustained recovery can be expected. The dividend yield stands at 2.42%.
CL Price Analysis
Market Metrics
Open
$88.38
Day Range
$86.67 to $90.49
Prev Close
$87.90
Volume
223.0K
52-Week Range
$74.55 to $99.33
Market Cap
$70.07B
Peer Benchmarking
Valuation vs Sector (Consumer Defensive)
Performance vs VDC
Sector Position Analysis
Trading at a significant premium to sector peers (+36%), suggesting market expectations for superior growth or market position.
CL Analysis
Company's Health
3/5
12-Month Analyst Target
+15.86% Upside
Median of 21 analysts (12-month)
$100.50
AI Technical Analysis
Colgate-Palmolive Co. is trading below its 50-day and 200-day moving averages ($91.47 and $87.89), and its 20-day EMA ($89.78), indicating a bearish trend. The Relative Strength Index (RSI) is at 27.58, signaling oversold conditions, which could suggest a potential bounce, but the MACD at -1.05 points to bearish momentum. The nearest support level is the current price of $86.74, with the 200-day SMA at $87.89 acting as resistance. Volume has been significantly below average, down 94.4%, suggesting a lack of conviction from traders. The stochastic indicator is at 1.19, also indicating oversold conditions. The combination of oversold indicators and bearish price action below key moving averages suggests caution, with a potential for a short-term rebound but a prevailing bearish sentiment.
ProTips
- Monitor insider transaction activity closely, as the recent heavy selling pressure may indicate short-term headwinds for Colgate-Palmolive Co.
- Given the stock is trading below its 50-day and 200-day moving averages ($91.47 and $87.89), consider waiting for a technical confirmation of a trend reversal before initiating new long positions.
- The dividend yield of 2.42% offers some income, but investors should weigh this against the current valuation premium and potential for price depreciation.
Key Catalysts
Bearish
Significant Insider Selling Pressure
Insiders have sold $57.3 million worth of Colgate-Palmolive Co. stock across 75 transactions, indicating a lack of confidence and potentially signaling near-term price weakness.
Source: Insider Trading DataBearish
Bearish Technical Momentum
Colgate-Palmolive Co. is trading below its 50-day and 200-day moving averages ($91.47 and $87.89), suggesting a bearish trend and potential for further price declines.
Source: Technical AnalysisBullish
Consistent Earnings Beats
The company has a track record of exceeding analyst EPS estimates, with the latest quarter showing a 4.21% surprise, which could provide underlying support if market sentiment shifts.
Source: Earnings ReportsNeutral
Steady Revenue Growth
Current year revenue growth is estimated at 5.00%, with next year projected at 3.00%, indicating a stable, albeit decelerating, top-line expansion in the consumer defensive sector.
Source: Revenue EstimatesMarket Outlook
Colgate-Palmolive Co.'s base case outlook is neutral, with a median analyst target price of $100.50 suggesting potential upside from the current $86.74. The company is expected to continue its revenue growth trajectory, albeit at a decelerating pace, with current year estimates at +5.00% and next year at +3.00%. The consistent earnings beats provide a foundation for stability. However, the bearish technical indicators, including the stock trading below its 50-day and 200-day moving averages ($91.47 and $87.89), and significant insider selling, present downside risks. A catalyst for upside could be a strong earnings report that reverses the negative technical momentum and alleviates insider selling concerns. Conversely, continued weakness in the stock price or further negative insider activity could push the stock towards its lower support levels.
Key Statistics
| Market Cap | 70.07B |
|---|---|
| P/E Ratio | 34.61 |
| EPS (TTM) | 2.54 |
| Dividend Yield | 2.42% |
| 52 Week High | 99.33 |
| 52 Week Low | 74.55 |
Colgate-Palmolive Co. (CL) presents a mixed fundamental picture with a P/E ratio of 34.61, which is above the sector average of 25.5, suggesting it is trading at a premium. The company's earnings per share (EPS) stands at $2.54. While revenue growth is projected at 5.00% for the current year, it is expected to slow to 3.00% next year, indicating a deceleration in top-line expansion. The company's profitability is supported by consistent earnings beats, but the valuation appears stretched relative to its growth prospects and sector averages. The dividend yield of 2.42% offers some return to shareholders, but the significant insider selling pressure and the premium valuation warrant a cautious approach. Investors should monitor future earnings reports and management commentary for signs of sustained growth acceleration to justify the current valuation.
Earnings & Growth Analysis
Colgate-Palmolive Co. has a history of positive earnings surprises, with the most recent quarter ending July 31, 2026, showing an EPS of $0.99 against an estimate of $0.95, a 4.21% beat, though the stock reacted negatively with a -1.56% price change. Prior to that, the quarter ending July 23, 2026, saw an EPS of $3.52 versus an estimate of $3.32, a 6.02% beat, with a positive stock reaction of +0.74%. The company has demonstrated an ability to meet or exceed analyst expectations, but the market's reaction has been mixed.
Key Risks
Colgate-Palmolive Co. faces significant risks including its elevated valuation relative to sector peers and decelerating revenue growth projections. The substantial insider selling, amounting to over $57 million, signals a potential lack of near-term confidence from management, which could weigh on investor sentiment. Also, the stock is trading below key technical indicators, suggesting potential for further price depreciation.
Technical Indicators
| RSI (14) | 27.58 |
|---|---|
| MACD | -1.05 |
| SMA 50 | 91.47 |
| SMA 200 | 87.89 |
RSI
Oversold
SMA Cross
Bullish
Price vs SMA
Bearish
MACD
Bearish
Golden Cross in effect with the 50-day SMA ($91.47) above the 200-day SMA ($87.89), price is trading below the 50-day SMA, RSI at 27.6 suggests oversold conditions; potential bounce setup.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.00
Weak correlation
Nasdaq 100 (QQQ)
-0.14
Weak correlation
Bitcoin (BTC)
-0.07
Weak correlation
Gold (XAU)
+0.03
Weak correlation
Check Custom Correlation
Calculating correlation...
CL Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies (click to switch)
CONSERVATIVE
$85.87
Slight discount to current
Wait for small dip
AGGRESSIVE
$86.74
At current price
Enter now if confident
Risk Management
STOP LOSS
$79.26
MAX LOSS
-7.7%
Volatility-Adjusted Stop Loss
Calculated based on RSI (27.6) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$88.45
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$90.17
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$92.74
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for CL is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 11, 2026.Growth of $10,000
A $10,000 investment in CL in September 2016 would be worth about $12,077 today, compared with about $35,030 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CL today could grow to about $15,205 by 2036 in the base case, with a bull case near $34,084 and a bear case around $6,783. Projections are statistical simulations, not guarantees.
CL Stock Price Prediction: 2030
CleaRank's simulation projects a price near $103 for CL by 2030 in the base case, from $86.74 today (1.2x over 4 years). The downside path ends near $61.56. These are outcomes of a Monte Carlo simulation run on CL's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $70.07 | $90.45 | $117 |
| 2028 | $65.74 | $94.32 | $135 |
| 2029 | $63.21 | $98.36 | $153 |
| 2030 | $61.56 | $103 | $171 |
| 2031 | $60.44 | $107 | $189 |
| 2032 | $59.68 | $112 | $208 |
| 2033 | $59.20 | $116 | $229 |
| 2034 | $58.92 | $121 | $250 |
| 2035 | $58.81 | $126 | $272 |
| 2036 | $58.84 | $132 | $296 |
Method: 10,000 simulated price paths using CL's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
CL Insider Trading Analysis
Bought
None
No open-market buys
Sold
$57.3M
14 Transactions
Insiders
19
Active Traders
Avg Transaction
$4.1M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | WALLACE NOEL R
Chief Executive Officer
|
Sell | 322.0K | $29.7M |
| Nov 5, 2021 | WALLACE NOEL R
Chief Executive Officer
|
Sell | 245.2K | $18.9M |
| Nov 4, 2020 | JAKOBSEN HENNING I.
Chief Financial Officer
|
Sell | 145.3K | $12.4M |
| Feb 4, 2026 | SUTULA STANLEY J III
Chief Financial Officer
|
Sell | 97.8K | $9.2M |
| Feb 20, 2024 | WALLACE NOEL R
Chief Executive Officer
|
Sell | 99.7K | $8.4M |
| Aug 5, 2020 | WALLACE NOEL R
Chief Executive Officer
|
Sell | 85.9K | $6.6M |
| Aug 12, 2020 | HUSTON JOHN J JR
Chairman of the Board
|
Sell | 84.9K | $6.6M |
| May 8, 2023 | PARAMESWARAN PRABHA
Officer
|
Sell | 64.4K | $5.2M |
| Feb 1, 2024 | DANIELS JENNIFER M
Officer
|
Sell | 61.6K | $5.2M |
| Feb 6, 2020 | MARSILI DANIEL B
Officer
|
Sell | 66.8K | $5.1M |
Page 1 of 1
Frequently Asked Questions
Is Colgate-Palmolive Co. stock a buy right now?
Colgate-Palmolive Co. (CL) is currently rated as a Hold. While the company has a history of earnings beats and consistent revenue growth, its stock is trading below key moving averages, and significant insider selling has been reported. The current price of $86.74 is below the median analyst target price of $100.5, suggesting potential upside, but the technical and insider selling signals warrant caution.
What is Colgate-Palmolive Co.'s price target?
The median analyst price target for Colgate-Palmolive Co. (CL) is $100.50, indicating an upside potential of 15.9% from the current price of $86.74. The highest target from analysts is $110, while the lowest is $87.
What are the biggest risks for Colgate-Palmolive Co.?
The primary risks for Colgate-Palmolive Co. include its premium valuation compared to sector averages, decelerating revenue growth forecasts, and significant insider selling pressure. The stock's current technical position below key moving averages also presents a risk of further downside.
How is Colgate-Palmolive Co. performing financially?
Colgate-Palmolive Co. has shown consistent revenue growth, with current year estimates at +5.00% and next year at +3.00%. Recent earnings have also shown positive surprises, with the latest quarter beating estimates by 4.21%. However, its P/E ratio of 34.61 is above the sector average, suggesting a potentially overvalued stock.
What is the outlook for Colgate-Palmolive Co. stock?
The outlook for Colgate-Palmolive Co. is neutral to cautious. While the company has a solid track record of earnings performance and revenue growth, current technical indicators are bearish, and significant insider selling raises concerns. The median analyst target price suggests upside, but near-term headwinds are present.
What is Colgate-Palmolive Co.'s dividend yield?
Colgate-Palmolive Co. offers a dividend yield of approximately 2.42%, with a dividend rate of $2.10. This provides a steady income stream for shareholders, although the stock's recent performance and insider selling warrant consideration.
Are insiders selling Colgate-Palmolive Co. stock?
Yes, insiders have been net sellers of Colgate-Palmolive Co. stock. Total sales have amounted to $57.3 million in recent filings, with no reported insider purchases. This heavy sell signal suggests a potential lack of confidence from management in the short term.